https://www.selleckchem.com/pr....oducts/Staurosporine
7% vs. 12.3%, p 0.01). Anatomically, anterior and apical recurrence was more common in the group not receiving PR (p 0.05). Concomitant PR was associated with a longer operating time and more blood loss (p 0.01). However, there were few adverse events related to PR, and the rates of de novo obstructed defecation and dyspareunia were low in both groups, with no significant difference between the groups. Concomitant PR at the time of native tissue apical suspension may reduce the recurrence of symptomatic anterior and